Eccrine Systems CEO Likens Much Of Noninvasive Wearables Market To Early 1900s Medicine
Cincinnati-based health tech startup Eccrine Systems has closed a $5.5 million Series A round, according to a news release. The funding will be used to advance its “sweatronics” platform, which uses a noninvasive wearable to measure the chemical makeup of the user’s sweat. The disposable electronic patch is designed to measure electrolytes and stress levels.
Eccrine is developing several different wearable devices based on the sweatronics platform, some of them will involve a U.S. Food and Drug Administration pathway for 510(k) clearance. But in a phone interview, Eccrine Systems CEO and Co-founder Robert Beech noted that the initial markets Eccrine is pursuing are for Class 1 medical devices that would not require FDA approval.
Eccrine is developing several different wearable devices based on the sweatronics platform, some of them will involve a U.S. Food and Drug Administration pathway for 510(k) clearance. But in a phone interview, Eccrine Systems CEO and Co-founder Robert Beech noted that the initial markets Eccrine is pursuing are for Class 1 medical devices that would not require FDA approval.